Cadre Holdings, Inc.·4

Jun 23, 4:15 PM ET

KANDERS WARREN B 4

Research Summary

AI-generated summary

Updated

Cadre (CDRE) 10% Owner Warren B. Kanders Sells 75,000 Shares

What Happened
Warren B. Kanders, reported as a 10% owner of Cadre Holdings, sold a total of 75,000 shares of Cadre common stock in two transactions. On 2026-06-18 he sold 25,000 shares at a weighted-average price of $27.86 (≈ $696,500), and on 2026-06-22 he sold 50,000 shares at a weighted-average price of $27.43 (≈ $1,371,500). The combined proceeds were approximately $2,068,000. These were sales (not purchases), which are typically routine dispositions rather than signals of positive bullish insider buying.

Key Details

  • Transaction dates and reported weighted-average prices:
    • 2026-06-18: 25,000 shares @ $27.86 (weighted avg; per footnote prices ranged $27.49–$28.42)
    • 2026-06-22: 50,000 shares @ $27.43 (weighted avg; per footnote prices ranged $27.28–$27.67)
  • Total shares sold: 75,000; total proceeds ≈ $2,068,000.
  • Post-transaction holdings: Not specified in the provided summary — see the filed Form 4 for the reporting person’s remaining holdings.
  • Notable footnotes:
    • Prices shown are weighted averages; the seller reports the trades occurred in multiple transactions at the stated price ranges and can provide a per-trade breakdown on request (Footnotes F1, F2).
    • Reporting structure: the Reporting Person is sole manager/member of Kanders SAF, LLC (F3); Allison Kanders is spouse (F4); the reporting person disclaims beneficial ownership except to the extent of pecuniary interest (F5).
  • Filing/timeliness: Form filed 2026-06-23 covering trades on 6/18 and 6/22. No late-filing flag was provided in the summary here — consult the official Form 4 for any timeliness notes.

Context: As a 10% owner (not a regular executive trade), these sales reflect disposals by a significant shareholder and are factual disclosures of transfers of shares; they do not, by themselves, indicate the reporting person’s view on Cadre’s prospects.